vimarsana.com


Gland Pharma Q4 results: Net profit rises 34% to Rs 260 cr
SECTIONS
Last Updated: May 17, 2021, 07:47 PM IST
Share
Synopsis
Consolidated revenue from operations of the company stood at Rs 887.7 crore for the quarter under consideration. It was Rs 635.2 crore in the year-ago period.
Consolidated revenue from operations for the financial year ended March 2021 was Rs 3,462.9 crore. It was Rs 2,633.2 crore in the preceding fiscal
Related
NEW DELHI: Drug firm Gland Pharma on Monday reported a 34 per cent rise in its consolidated net profit to Rs 260.4 crore for the fourth quarter ended March 2021, on account of robust sales.
The company had posted a net profit of Rs 194.8 crore for the corresponding period of the previous fiscal, Gland Pharma said in a BSE filing.

Related Keywords

Naina Lal Kidwai ,Srinivas Sadu ,Allen Zhang , ,Gland Pharma ,Net Profit ,Earnings ,Revenue ,New Vaccine Business ,Gland Pharma Q4 ,Biosimilar ,நைனா லால் கிடுவாய் ,ஸ்ரீநிவாஸ் சாது ,ஆலன் ஜாங் ,சுரப்பி பார்மா ,நிகர ப்ராஃபிட் ,வருவாய் ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.